PCV regimen: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[procarbazine]], [[lomustine|lomustine (CCNU)]] and [[vincristine]] used for the treatment of low grade, adult [[oligodendroglioma| | {{PAGENAME}} refers to a regimen consisting of [[procarbazine]], [[lomustine|lomustine (CCNU)]] and [[vincristine]] used for the treatment of low grade, adult [[oligodendroglioma|oligodendroglial tumors]].<ref name="pmid17388986">{{cite journal| author=Lebrun C, Fontaine D, Bourg V, Ramaioli A, Chanalet S, Vandenbos F et al.| title=Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. | journal=Eur J Neurol | year= 2007 | volume= 14 | issue= 4 | pages= 391-8 | pmid=17388986 | doi=10.1111/j.1468-1331.2007.01675.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17388986 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63491&ns=NCI_Thesaurus}}</ref> | ||
==Regimen== | ==Regimen== | ||
Line 16: | Line 16: | ||
==Indications== | ==Indications== | ||
*Low grade, adult [[oligodendroglioma| | *Low grade, adult [[oligodendroglioma|oligodendroglial tumors]]<ref name="pmid17388986">{{cite journal| author=Lebrun C, Fontaine D, Bourg V, Ramaioli A, Chanalet S, Vandenbos F et al.| title=Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. | journal=Eur J Neurol | year= 2007 | volume= 14 | issue= 4 | pages= 391-8 | pmid=17388986 | doi=10.1111/j.1468-1331.2007.01675.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17388986 }} </ref> | ||
==References== | ==References== |
Latest revision as of 18:55, 27 March 2015
WikiDoc Resources for PCV regimen |
Articles |
---|
Most recent articles on PCV regimen Most cited articles on PCV regimen |
Media |
Powerpoint slides on PCV regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on PCV regimen at Clinical Trials.gov Clinical Trials on PCV regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on PCV regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on PCV regimen Discussion groups on PCV regimen Patient Handouts on PCV regimen Directions to Hospitals Treating PCV regimen Risk calculators and risk factors for PCV regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for PCV regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: PCV Regimen; Procarbazine-CCNU-Vincristine Regimen
Overview
PCV regimen refers to a regimen consisting of procarbazine, lomustine (CCNU) and vincristine used for the treatment of low grade, adult oligodendroglial tumors.[1][2]
Regimen
PProcarbazine
CLomustine (CCNU)
VVincristine
Indications
- Low grade, adult oligodendroglial tumors[1]
References
- ↑ 1.0 1.1 Lebrun C, Fontaine D, Bourg V, Ramaioli A, Chanalet S, Vandenbos F; et al. (2007). "Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy". Eur J Neurol. 14 (4): 391–8. doi:10.1111/j.1468-1331.2007.01675.x. PMID 17388986.
- ↑ "NCI Thesaurus".